TY - JOUR
T1 - Equitable colorectal cancer screening implementation framework via a modified Delphi Consensus for Romanian healthcare
AU - The SCREECO study group
AU - Negoi, Ionut
AU - Zubayraeva, Albina
AU - Verras, Georgios Ioannis
AU - van Ramshorst, Gabrielle
AU - Ungureanu, Andreea Catalina
AU - Ungureanu, Alexia
AU - Tudorascu, Stefana Ilinca
AU - Tudor, Alexandru Vicentiu
AU - Toma, Elena Adelina
AU - Toma, Ciprian
AU - Tantau, Marcel
AU - Stojkovski, Kire
AU - Stoica, Bogdan
AU - Silviu, Makkai
AU - Shalaby, Mostafa
AU - Seretis, Charalampos
AU - Seppälä, Toni
AU - Saïd, Haddadi
AU - Sartelli, Massimo
AU - Sandru, Vasile
AU - Munteanu, Laura Elena Roșu
AU - Rodrigo, Luis
AU - Gabriel, Lupu Robert
AU - Pucheanu, Xenia
AU - Popescu, Sorin Stefan
AU - Pellino, Gianluca
AU - Patel, Tapan
AU - Pata, Francesco
AU - Otabekov, Akmalbek
AU - Obaid, Omar Rabah
AU - Negoi, Ruxandra
AU - Natalia, Velenciuc
AU - Musina, Ana Maria
AU - Mulita, Francesk
AU - Morar, Anca
AU - Moldoveanu, Alin
AU - Mirica, Radu Mihail
AU - Marin, Iuliana
AU - Maeda, Yasuko
AU - Lupu, Robert Gabriel
AU - Lunca, Sorinel
AU - Kok, Kenneth Y.Y.
AU - Jan, Hizbullah
AU - Ionescu, Victor Stefan
AU - Tănase, Ioan
AU - Herteliu, Claudiu
AU - Grama, Florin
AU - Ginghina, Octav
AU - Garoufalia, Zoe
AU - Garofil, Dragos
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Colorectal cancer (CRC) continues to be a predominant cause of cancer-related mortality on a global scale. Screening for early detection plays a crucial role in significantly reducing both incidence and mortality rates. However, screening uptake varies widely across regions due to disparities in healthcare resources and implementation of screening programs. The aim of this study was to evaluate various potential strategies for implementing an effective colorectal cancer screening program that enhances adherence. This program should be feasible and appropriate, considering the demographic characteristics, geographical distribution, and logistical factors, including human and material resources, of medical facilities at the national level in Romania. A multidisciplinary panel was convened using a modified Delphi process (two survey rounds and a consensus meeting in early 2022) to develop a harmonized CRC screening framework tailored to diverse healthcare settings. Clinicians and allied professionals from 19 countries (Europe, Asia, and Africa) contributed to the consensus recommendations for average-risk individuals. The panel advised that primary care physicians should play a central role in CRC risk assessment and patient engagement and endorsed initiating screening at age 45 and continuing to 75, with selective extension up to 85 for healthy, willing individuals. To improve participation, we recommended region-specific screening strategies that accommodate local resources and demographics and emphasized a patient-centered approach offering multiple modalities (colonoscopy, fecal immunochemical testing, CT colonography), emphasizing that the most effective test is one that patients are willing to complete. Finally, the study group deemed implementing a centralized system for screening invitations, result tracking, and patient recall essential. This consensus guideline provides a scalable model to enhance screening adherence and reduce CRC mortality through early detection and prevention. This framework is developed for the Romanian healthcare context, informed by international professional input but tailored to local healthcare infrastructure and estimated population needs.
AB - Colorectal cancer (CRC) continues to be a predominant cause of cancer-related mortality on a global scale. Screening for early detection plays a crucial role in significantly reducing both incidence and mortality rates. However, screening uptake varies widely across regions due to disparities in healthcare resources and implementation of screening programs. The aim of this study was to evaluate various potential strategies for implementing an effective colorectal cancer screening program that enhances adherence. This program should be feasible and appropriate, considering the demographic characteristics, geographical distribution, and logistical factors, including human and material resources, of medical facilities at the national level in Romania. A multidisciplinary panel was convened using a modified Delphi process (two survey rounds and a consensus meeting in early 2022) to develop a harmonized CRC screening framework tailored to diverse healthcare settings. Clinicians and allied professionals from 19 countries (Europe, Asia, and Africa) contributed to the consensus recommendations for average-risk individuals. The panel advised that primary care physicians should play a central role in CRC risk assessment and patient engagement and endorsed initiating screening at age 45 and continuing to 75, with selective extension up to 85 for healthy, willing individuals. To improve participation, we recommended region-specific screening strategies that accommodate local resources and demographics and emphasized a patient-centered approach offering multiple modalities (colonoscopy, fecal immunochemical testing, CT colonography), emphasizing that the most effective test is one that patients are willing to complete. Finally, the study group deemed implementing a centralized system for screening invitations, result tracking, and patient recall essential. This consensus guideline provides a scalable model to enhance screening adherence and reduce CRC mortality through early detection and prevention. This framework is developed for the Romanian healthcare context, informed by international professional input but tailored to local healthcare infrastructure and estimated population needs.
KW - Colorectal cancer
KW - Delphi consensus
KW - Early detection
KW - Guidance
KW - Healthcare disparities
KW - Radical resection
KW - Screening
KW - Screening adherence
KW - 3122 Cancers
U2 - 10.1038/s41598-025-26713-7
DO - 10.1038/s41598-025-26713-7
M3 - Article
C2 - 41315358
AN - SCOPUS:105023334939
SN - 2045-2322
VL - 15
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 42692
ER -